Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Medicalgorithmics

AI Verdict

Tool A is designed for real-time prediction and management of hypotensive events in critical care and surgical settings, leveraging continuous hemodynamic monitoring. In contrast, Tool B specializes in the AI-powered detection and classification of cardiac arrhythmias from ECG data, aiming to improve diagnostic accuracy and efficiency in cardiology workflows. While both utilize AI in cardiology, they address distinct clinical challenges and are not direct competitors.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary goal is the proactive, real-time management and prevention of hypotensive events in dynamic clinical environments like the operating room or ICU. This tool is ideal for anesthesiologists and critical care teams needing to anticipate and intervene in hemodynamic instability up to 15 minutes before it occurs, leveraging continuous monitoring and machine learning insights to reduce intraoperative hypotension.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your focus is on revolutionizing the accuracy and efficiency of cardiac arrhythmia detection and classification from ECG data across a large volume of patients. This cloud-based AI algorithm is best suited for cardiologists and healthcare systems aiming to significantly reduce missed diagnoses and streamline ECG reporting workflows, integrating seamlessly with various ECG devices for superior diagnostic capabilities.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform DeepRhythmAI
Pricing Unknown Contact vendor for pricing information
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A provides a complete, integrated user experience with a dedicated interface for real-time monitoring and decision support within the Edwards Lifesciences platform. In contrast, Tool B, while powerful, functions as a backend engine and requires integration with external visualization software for a complete user interface, making its direct usability lower for the end clinician.

Clinical Value

DeepRhythmAI

Both tools offer significant clinical value, but DeepRhythmAI (Tool B) provides strong, quantifiable claims of drastically reducing missed diagnoses by 14x to 114x and improving workflow efficiency by up to 65%. These metrics demonstrate a profound and measurable impact on diagnostic accuracy and operational effectiveness, giving it an edge in clinical value.

Pricing & Value

DeepRhythmAI

Both tools have opaque pricing, making a direct comparison challenging. However, Tool B's cloud-based, device-agnostic deployment model and API availability suggest greater flexibility and potentially a lower barrier to entry or more scalable cost structure compared to Tool A's dependency on specific, integrated hardware platforms.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI (Tool B) demonstrates superior enterprise readiness with comprehensive compliance certifications including HIPAA, GDPR, HITECH, SOC 2, and ISO/IEC 27001, alongside support for multiple data standards like FHIR, HL7, and DICOM. Its cloud-based, device-agnostic deployment with an API offers broader integration capabilities and scalability for diverse healthcare environments than Tool A's more specialized integration within the Edwards Lifesciences ecosystem.

Innovation

DeepRhythmAI

While both are innovative, DeepRhythmAI (Tool B) leverages cutting-edge AI models, specifically Transformer models, trained on an exceptionally vast dataset of over 250 billion annotated heartbeats for superior diagnostic accuracy and efficiency. This advanced methodological foundation and scale of training data represent a more significant push in AI innovation within its domain compared to Tool A's predictive capabilities.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

As a product from Edwards Lifesciences, a global leader in medical technology, Acumen HPI (Tool A) benefits from the extensive and well-established support, training, and documentation infrastructure typically provided for complex, integrated critical care platforms. DeepRhythmAI (Tool B), while having global customers, does not provide specific details on its support offerings in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform DeepRhythmAI
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform DeepRhythmAI
Company Edwards Lifesciences Medicalgorithmics S.A.
Description The Acumen Hypotension Prediction Index (HPI) software by Edwards Lifesciences uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. DeepRhythmAI is an FDA-cleared, cloud-based AI algorithm by Medicalgorithmics S.A. that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.
Categories Cardiology AI, Surgical AI, Triage & ER/ICU AI Cardiology AI, Clinical Decision Support & Reference
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Key Features HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Smart Trend screen, Relationship View screen (preload, afterload, contractility insights), Machine learning-based algorithm for prediction, Predicts hypotension up to 15 minutes in advance, Continuous hemodynamic monitoring, Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options AI-powered arrhythmia detection and classification, Utilizes CNN and Transformer models, Trained on 250 billion+ annotated heartbeats, Device-agnostic and integrates with various ECG devices, Cloud-based software, Faster ECG reporting and analysis, Reduces missed diagnoses (14x to 114x fewer), Streamlines clinical workflows (up to 65% efficiency increase)

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and DeepRhythmAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is designed for real-time, continuous hemodynamic monitoring in acute care settings like the OR or ICU, predicting hypotension up to 15 minutes in advance to guide immediate intervention. DeepRhythmAI, conversely, focuses on revolutionizing cardiac arrhythmia detection and classification from ECG data, streamlining diagnostic workflows and reporting efficiency, often for retrospective assessment.
Acumen HPI integrates with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors, implying data flows from this specific monitoring system. DeepRhythmAI is device-agnostic and offers a robust API for seamless integration with various ECG devices and EMR systems, suggesting more flexible interoperability.
Acumen HPI's machine learning algorithm predicts hypotensive events up to 15 minutes in advance, with studies showing high sensitivity and specificity (e.g., 89% specificity and 90% sensitivity at 10 minutes before an event). DeepRhythmAI offers superior accuracy in cardiac arrhythmia detection, claiming to reduce missed diagnoses by 14x to 114x and demonstrating high sensitivity (e.g., 98.6% for critical arrhythmias) compared to technician analysis.
Acumen HPI presents a HPI score, Smart Alerts, Smart Trend, and Relationship View screens, requiring familiarity with hemodynamic parameters and the system's visual cues for interpretation and decision-making. DeepRhythmAI streamlines ECG reporting and analysis through AI-powered arrhythmia detection and classification, aiming to simplify the diagnostic process and improve efficiency for physicians and technicians.
Acumen HPI requires integration with the Edwards Lifesciences HemoSphere platform and dedicated sensors, suggesting a hardware-dependent rollout across sites. DeepRhythmAI, being cloud-based, device-agnostic, and offering an API, is designed for easier scalability and integration with various existing ECG devices across numerous healthcare providers globally.
DeepRhythmAI is utilized by numerous healthcare providers globally, with its performance independently proven by studies like DRAI MARTINI, indicating a broad customer base and established presence. Acumen HPI is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, a widely used system, and its effectiveness in reducing intraoperative hypotension has been demonstrated in multiple clinical studies.
AI Tool Finder
AI-powered search. Results may not be comprehensive.